The Spain Compression Therapy Market was valued at $41.6 Million in 2025 and projected to reach to $52.7 Million by 2030, representing a compound annual growth rate of 4.8%. Spain's compression therapy market is positioned for consistent growth driven by demographic aging and rising chronic disease prevalence.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Spain's compression therapy market is valued at $41.6 million in 2025, with a projected CAGR of 4.8% through 2030, reaching $52.7 million. This steady growth reflects increasing healthcare investment in chronic disease management across Spanish regions.
Spain has one of Europe's oldest populations, with over 19% aged 65+. This demographic shift significantly increases prevalence of venous insufficiency and lymphedema, creating sustained demand for compression therapy solutions in both clinical and home care settings.
Spanish healthcare providers are expanding compression therapy adoption beyond traditional venous care into sports medicine, post-surgical recovery, and athletic performance enhancement. This diversification is broadening the addressable market across multiple medical specialties.
Spain's decentralized healthcare system across autonomous communities is driving localized adoption of compression therapy. Regional hospitals and private clinics are increasingly integrating these solutions into treatment protocols for chronic conditions.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | LYMPHEDEMA TREATMENT (Application) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 5.5% from 2025 to 2030 |
| Largest Segment | STATIC COMPRESSION THERAPY (Technique) |
| Market Size Base Year (Billions) | ~USD 4.51 (2025) |
| Revenue Forecast (Billions) | ~USD 5.9 (2030) |
| Segments Covered | Product, Technique, Application, Distribution Channel, Type |
5 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| DEVON MEDICAL PRODUCTS | United States | Private Company | Pneumatic compression (dynamic),Stockings (static),Wraps and bandages (static), |
| KINDRED HEALTHCARE INC. | United States | Private Company | Bandage,Wraps,Stockings, |
| BEIERSDORF AG | Germany | Public Company | Bandages,Wraps,Stockings, |
| SOLVENTUM CORPORATION (3M) | United States | ||
| ENOVIS CORPORATION | United States | Public Company | Static compression (bandages, wraps, stockings, tapes),Braces with integrated compression,Dynamic/pneumatic compression systems, |
| BSN MEDICAL (A SUBSIDIARY OF ESSITY) | Sweden | ||
| CARDINAL HEALTH | United States | Public Company | Bandages & Wraps,Stockings,Tapes, |
| TACTILE MEDICAL | United States | Public Company | Pneumatic compression systems (Flexitouch Plus, Entre Plus, Nimbl),Software and digital engagement (Kylee app, connectivity, services),Non-compression respiratory therapy (AffloVest), |
| CONVATEC INC. | United Kingdom | Public Company | Static compression (bandages, wraps, stockings, tapes, braces),Dynamic compression (pneumatic devices), |
| MEDI GMBH & CO. KG | Taiwan | Public Company | Stockings (Static),Wraps & Braces (Static),Bandages & Tapes (Static), |
| PAUL HARTMANN | Germany | Public Company | Bandages (compression, universal, zinc paste, padding),Wraps and Stockings,Tapes and Braces, |
| SMITH+NEPHEW | United Kingdom | Public Company | Bandage,Wraps,Stockings, |
Devon Medical Products is a private medical products company founded in 2005 and based in the United States.
Kindred Healthcare Inc. is a private healthcare company founded in 1985 in the United States with 64,200 employees.
Beiersdorf AG is a German public company founded in 1882 with 21,589 employees, operating in the healthcare and consumer goods sectors.
Insufficient data available to provide a business description for Solventum Corporation (3M).
Enovis Corporation is a public medical technology company founded in 1995 in the United States with 7,802 employees.
Insufficient data available to provide a business description for BSN Medical (a subsidiary of Essity).
Cardinal Health is a public healthcare services and pharmaceutical distribution company founded in 1979 in the United States with 55,392 employees.
Tactile Medical is a public medical device company founded in 1995 in the United States with 1,086 employees.
ConvaTec Inc. is a public medical products and healthcare company founded in 1978 in the United Kingdom with 10,910 employees.
Medi GmbH & Co. KG is a public medical device company founded in 1997 based in Taiwan with 17,449 employees.
Paul Hartmann is a German public healthcare company founded in 1818 with 10,066 employees.
Smith+Nephew is a public medical devices and healthcare company founded in 1856 in the United Kingdom with 16,988 employees.
Spain's compression therapy market is valued at $41.6 million in 2025 and is projected to reach $52.7 million by 2030.
Spain's compression therapy market is expected to grow at a compound annual growth rate (CAGR) of 4.8% from 2025 to 2030.
Spain's compression therapy demand is driven by an aging population, rising prevalence of chronic venous diseases, increased clinical awareness, and strong healthcare infrastructure supporting therapeutic innovation.
Spain's compression therapy market is dominated by applications in venous insufficiency treatment, lymphedema management, and sports medicine recovery across hospital, clinic, and home care settings.
Spain's 4.8% CAGR reflects moderate growth aligned with European healthcare trends, supported by strong regulatory frameworks and integration within the EU healthcare ecosystem.
The size of the compression therapy market was based on four primary studies to ensure accuracy. Initial data for the compression therapy market and related sectors was gathered from 3 to 5 secondary sources. This information was then validated through primary research to confirm the assumptions and overall market sizing. Both top-down and bottom-up approaches were employed to determine the total market size, which was subsequently refined into segment and subsegment sizes. Finally, data triangulation was conducted to verify the accuracy of the findings.
Secondary research sources included directories, Factiva, white papers, Bloomberg Business, annual reports, SEC filings, business filings, and investor presentations. These sources offered valuable insights into market leaders, sector divisions, and technological differences within various segments of the compression therapy industry.
Primary research consisted of both quantitative and qualitative insights gathered through interviews with key stakeholders. On the demand side, participants included physicians, researchers, department heads, and staff from diagnostic centers, hospitals, and research institutes. On the supply side, interviews were conducted with CEOs, area sales managers, territory and regional sales managers, and other top executives from relevant companies. These direct conversations helped validate the findings from secondary research and provided an opportunity to directly question and confirm assumptions.
A breakdown of the primary respondents is provided below.
Note q: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
This report utilized the revenue share analysis of major companies to evaluate the size of the global compression therapy market. This analysis involved identifying key market participants and calculating their revenue from compression therapy using a variety of data collected during both primary and secondary research phases. One aspect of the secondary research included reviewing the annual and financial reports of leading market players. Conversely, primary research consisted of detailed interviews with influential thought leaders, including directors, CEOs, and key marketing executives.
To determine the overall market value, the segmental revenue was calculated by mapping the revenue of the leading solution and service providers. The process involved several steps.

To ensure accurate data, the compression therapy market was divided into various segments and subsegments. A data triangulation process that used both top-down and bottom-up approaches was applied. This involved analyzing factors and trends from both the demand and supply sides to validate the findings for each segment. The combination of this segmentation with the triangulation process helps ensure that the market data is both accurate and reliable.
Compression therapy is the process of applying controlled pressure to the lower extremities to increase and improve blood flow to the heart. This mode of treatment utilizes the elastic properties of compression garments or the pneumatic force of compression devices to address specific clinical requirements as part of disease management. The compression therapy market is primarily used for managing venous disorders, lymphedema, wound care, post-surgical recovery, and sports injuries. It enhances blood circulation, reduces swelling, and promotes healing, commonly through compression garments, bandages, and devices like pneumatic pumps. Key settings include hospitals, clinics, and home care.
Full forecast, segment splits, and company analysis for all Compression Therapy Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report